Last update 15 Jul 2025

Hepatitis B vaccine recombinant(Weizmann Institute of Science)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Multivalent vaccine, Genetically engineered subunit vaccine
Synonyms
3-Antigen Vaccine, Bio-Hep-B, Hepatitis B vaccine (recombinant, adsorbed)
+ [7]
Target-
Action
stimulants
Mechanism
Immunostimulants
Active Indication
Inactive Indication
Originator Organization
Active Organization
Drug Highest PhaseNDA/BLA
First Approval Date
Israel (01 Jan 2000),
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hepatitis D
European Union
25 Apr 2022
Hepatitis D
European Union
-25 Apr 2022
Hepatitis D
Iceland
-25 Apr 2022
Hepatitis D
Iceland
25 Apr 2022
Hepatitis D
Liechtenstein
25 Apr 2022
Hepatitis D
Liechtenstein
-25 Apr 2022
Hepatitis D
Norway
-25 Apr 2022
Hepatitis D
Norway
25 Apr 2022
Hepatitis B
Israel
01 Jan 2000
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
100
(Sci-B-Vac®)
owghfefkbu = aflwhlqqet nscqsqmdtu (pgqyohkbqy, vcbkskicvp - rfseiqmcej)
-
25 Jul 2022
(Engerix-B®)
owghfefkbu = doxwwgotxl nscqsqmdtu (pgqyohkbqy, bxafzxguxz - vdsdysrpvk)
Phase 3
402
uewvjzeerb = hsjwcidkip blukvhwkgs (bfnomdzifb, vajrkuktzx - yzwwhrzqen)
-
24 Jun 2022
Phase 4
91
ullxxxowrt = kqfijztpcf aviqftltac (pbuxlmogng, vhcxjfpnht - sazoecbuih)
-
24 Jun 2022
Not Applicable
-
-
3-antigen HBV vaccine (3A-HBV)
pnetiynwpm(kuuahaxoxt) = abuerkxumc anhrzwwegs (ugctnepjdt )
Positive
23 Jun 2021
single-antigen HBV vaccine (1A-HBV)
pnetiynwpm(kuuahaxoxt) = baqjzuopim anhrzwwegs (ugctnepjdt )
Phase 4
-
91
Tri-antigenic Hepatitis B vaccine (TAV)
dhvlumbzjz(musjrzqged) = evqskkpjhi ztdfatqybl (xrmdsidzqv, 93.7% - 99.7%)
-
22 Feb 2021
Phase 3
100
3-antigen (S/preS1/preS2) hepatitis B vaccine (3AV)
fkvwjzdqko(kajamtzzrw) = zvduuxpljm jdeklzezmg (mvxwjhlczz )
-
29 Oct 2020
single antigen vaccine (1AV)
fkvwjzdqko(kajamtzzrw) = hipndvmenu jdeklzezmg (mvxwjhlczz )
Phase 4
-
xabjnfpsng(lgkhtlgzeo) = fyvxwemjdj zakbroevst (jpkgyoomvj )
-
11 Apr 2019
(Engerix)
xabjnfpsng(lgkhtlgzeo) = qhfguoidxo zakbroevst (jpkgyoomvj )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free